new developed drug screening feasibility approach demonstrated identification new immunomodulating compounds peripheral blood mononuclear cells chosen cellular assay cells stimulated produce t cell cytokines asthma targets stimulated lipopolysaccharide produce proinflammatory cytokines targets chronic obstructive pulmonary disease copd authors developed new fully automated rna purification cells grown plates gene expression determined plates using quantitative rtpcr small interdonor variation demonstrated assay validated known immunosuppressants cyclosporine dexamethasone screening NUMBER compounds resulted NUMBER compounds inhibiting induction NUMBER t cell derived cytokine NUMBER compounds inhibiting NUMBER cytokine relevant copd compounds retested analyzing remaining rna 1st round screening reproducibility hits NUMBER NUMBER different cytokines compound selectively inhibited tnf confirmed ic50 determination analyzing effect cells different donors revealed little interdonor variation conclusion authors established fully automated rna isolation precise gene expression profiling using rtpcr drug screening rna based NUMBER NUMBER real time tube real time tpa ionomycin